1189460-62-5 Usage
Description
TRIMETHOPRIM-D9 MAJOR is a deuterated form of Trimethoprim, an antibacterial agent. It is an off-white solid and contains 90% D9, 10% D6, and no D0. TRIMETHOPRIM-D9 MAJOR is known for its effectiveness in treating bacterial infections and has potential applications in various industries.
Uses
Used in Pharmaceutical Industry:
TRIMETHOPRIM-D9 MAJOR is used as an antibacterial agent for treating bacterial infections. Its deuterated nature enhances the stability and effectiveness of the compound, making it a valuable asset in the development of new antibiotics and treatment options for various bacterial diseases.
Used in Research and Development:
TRIMETHOPRIM-D9 MAJOR is used as a research compound for studying the properties and mechanisms of action of Trimethoprim and its deuterated forms. This helps in understanding the potential improvements in drug design and development, as well as exploring new applications in the field of medicine.
Used in Drug Delivery Systems:
TRIMETHOPRIM-D9 MAJOR can be employed in the development of novel drug delivery systems to enhance the bioavailability, targeting, and therapeutic outcomes of the antibacterial agent. This may involve the use of various carriers, such as organic and metallic nanoparticles, to improve the delivery and efficacy of the compound against bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1189460-62-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,9,4,6 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1189460-62:
(9*1)+(8*1)+(7*8)+(6*9)+(5*4)+(4*6)+(3*0)+(2*6)+(1*2)=185
185 % 10 = 5
So 1189460-62-5 is a valid CAS Registry Number.
1189460-62-5Relevant articles and documents
Synthesis of deuterium-labelled drugs by hydrogen-deuterium (H-D) exchange using heterogeneous catalysis
Modutlwa, Nkaelang,Maegawa, Tomohiro,Monguchi, Yasunari,Sajiki, Hironao
experimental part, p. 686 - 692 (2011/09/16)
Multi-deuterium incorporations into drugs, such as theophylline, caffeine, valpromide, phenytoin, and trimethoprim, were post-synthetically achieved by Pd/C-, Pt/C-, or/and Rh/C-catalyzed hydrogen-deuterium exchange reactions under neutral conditions usin